Posted on February 9, 20232/9/23
Inside the Pharma Name Game: Drug Word Choice Key to Building a Lasting Identity
Posted on February 8, 20232/8/23
MM+M Podcast 2.8.23: Eisai’s pricing transparency, GAO’s report on ‘gain-of-function’ research and MrBeast’s polarizing video
Posted on February 7, 20232/7/23
ChatGPT and generative AI land in pharma marketing with sense of awe — and plenty of caution
Posted on February 1, 20232/1/23
2023 Pharma Choice App Gold Winner EVERSANA INTOUCH and The Chrysalis Initiative
Posted on February 1, 20232/1/23
2023 Pharma Choice Self-promotion/Corporate Campaign Silver Winner EVERSANA INTOUCH
Posted on February 1, 20232/1/23
2023 Pharma Choice Philanthropic Gold Winner EVERSANA INTOUCH and The Chrysalis Initiative
Posted on February 1, 20232/1/23
2023 PM360 Pharma Choice Award Winners
Posted on January 26, 20231/26/23
Taking Oncology Therapies to Market Requires Change in Commercialization Models
Posted on January 18, 20231/18/23
40 Under 40: Sean Rapson, EVERSANA CONSULTING
Posted on January 4, 20231/4/23
